Free Trial

Mirion Technologies (MIR) Competitors

Mirion Technologies logo
$19.93 -0.46 (-2.25%)
As of 11:00 AM Eastern
This is a fair market value price provided by Massive. Learn more.

MIR vs. NVMI, RVTY, CAMT, BIO.B, and ST

Should you be buying Mirion Technologies stock or one of its competitors? The main competitors of Mirion Technologies include Nova (NVMI), Revvity (RVTY), Camtek (CAMT), Bio-Rad Laboratories (BIO.B), and Sensata Technologies (ST). These companies are all part of the "measuring and control equipment" industry.

How does Mirion Technologies compare to Nova?

Nova (NASDAQ:NVMI) and Mirion Technologies (NYSE:MIR) are both measuring and control equipment companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, valuation, media sentiment, analyst recommendations, dividends, risk and institutional ownership.

Nova has a net margin of 29.44% compared to Mirion Technologies' net margin of 2.56%. Nova's return on equity of 22.90% beat Mirion Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Nova29.44% 22.90% 13.65%
Mirion Technologies 2.56%6.44%3.48%

83.0% of Nova shares are held by institutional investors. Comparatively, 78.5% of Mirion Technologies shares are held by institutional investors. 1.0% of Nova shares are held by company insiders. Comparatively, 6.3% of Mirion Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Nova has a beta of 1.78, indicating that its share price is 78% more volatile than the S&P 500. Comparatively, Mirion Technologies has a beta of 1.07, indicating that its share price is 7% more volatile than the S&P 500.

In the previous week, Mirion Technologies had 9 more articles in the media than Nova. MarketBeat recorded 17 mentions for Mirion Technologies and 8 mentions for Nova. Nova's average media sentiment score of 1.12 beat Mirion Technologies' score of 0.79 indicating that Nova is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Nova
4 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Mirion Technologies
9 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Nova presently has a consensus price target of $442.25, indicating a potential downside of 15.26%. Mirion Technologies has a consensus price target of $27.13, indicating a potential upside of 36.09%. Given Mirion Technologies' higher possible upside, analysts clearly believe Mirion Technologies is more favorable than Nova.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nova
0 Sell rating(s)
2 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.80
Mirion Technologies
1 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.80

Nova has higher earnings, but lower revenue than Mirion Technologies. Nova is trading at a lower price-to-earnings ratio than Mirion Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nova$880.58M18.83$259.22M$8.0165.15
Mirion Technologies$925.40M5.40$28.80M$0.10199.32

Summary

Nova beats Mirion Technologies on 10 of the 16 factors compared between the two stocks.

How does Mirion Technologies compare to Revvity?

Revvity (NYSE:RVTY) and Mirion Technologies (NYSE:MIR) are both measuring and control equipment companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, valuation, media sentiment, analyst recommendations, dividends, risk and institutional ownership.

Revvity has a net margin of 8.26% compared to Mirion Technologies' net margin of 2.56%. Revvity's return on equity of 8.00% beat Mirion Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Revvity8.26% 8.00% 4.83%
Mirion Technologies 2.56%6.44%3.48%

Revvity has a beta of 1.05, indicating that its share price is 5% more volatile than the S&P 500. Comparatively, Mirion Technologies has a beta of 1.07, indicating that its share price is 7% more volatile than the S&P 500.

In the previous week, Revvity had 15 more articles in the media than Mirion Technologies. MarketBeat recorded 32 mentions for Revvity and 17 mentions for Mirion Technologies. Mirion Technologies' average media sentiment score of 0.79 beat Revvity's score of 0.42 indicating that Mirion Technologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Revvity
7 Very Positive mention(s)
3 Positive mention(s)
14 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Mirion Technologies
9 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

86.7% of Revvity shares are held by institutional investors. Comparatively, 78.5% of Mirion Technologies shares are held by institutional investors. 0.9% of Revvity shares are held by company insiders. Comparatively, 6.3% of Mirion Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Revvity has higher revenue and earnings than Mirion Technologies. Revvity is trading at a lower price-to-earnings ratio than Mirion Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Revvity$2.90B3.85$241.20M$2.0947.85
Mirion Technologies$925.40M5.40$28.80M$0.10199.32

Revvity presently has a consensus price target of $106.82, indicating a potential upside of 6.82%. Mirion Technologies has a consensus price target of $27.13, indicating a potential upside of 36.09%. Given Mirion Technologies' stronger consensus rating and higher possible upside, analysts clearly believe Mirion Technologies is more favorable than Revvity.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Revvity
1 Sell rating(s)
8 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.23
Mirion Technologies
1 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.80

Summary

Mirion Technologies beats Revvity on 9 of the 17 factors compared between the two stocks.

How does Mirion Technologies compare to Camtek?

Camtek (NASDAQ:CAMT) and Mirion Technologies (NYSE:MIR) are both mid-cap measuring and control equipment companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, media sentiment, dividends, risk, valuation, profitability and institutional ownership.

Camtek has a net margin of 10.23% compared to Mirion Technologies' net margin of 2.56%. Camtek's return on equity of 23.61% beat Mirion Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Camtek10.23% 23.61% 12.93%
Mirion Technologies 2.56%6.44%3.48%

Camtek has a beta of 1.61, suggesting that its stock price is 61% more volatile than the S&P 500. Comparatively, Mirion Technologies has a beta of 1.07, suggesting that its stock price is 7% more volatile than the S&P 500.

In the previous week, Mirion Technologies had 12 more articles in the media than Camtek. MarketBeat recorded 17 mentions for Mirion Technologies and 5 mentions for Camtek. Mirion Technologies' average media sentiment score of 0.79 beat Camtek's score of 0.72 indicating that Mirion Technologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Camtek
2 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Mirion Technologies
9 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

41.9% of Camtek shares are held by institutional investors. Comparatively, 78.5% of Mirion Technologies shares are held by institutional investors. 79.4% of Camtek shares are held by company insiders. Comparatively, 6.3% of Mirion Technologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Camtek has higher earnings, but lower revenue than Mirion Technologies. Mirion Technologies is trading at a lower price-to-earnings ratio than Camtek, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Camtek$496.07M18.22$50.72M$0.94209.75
Mirion Technologies$925.40M5.40$28.80M$0.10199.32

Camtek currently has a consensus price target of $166.75, indicating a potential downside of 15.43%. Mirion Technologies has a consensus price target of $27.13, indicating a potential upside of 36.09%. Given Mirion Technologies' stronger consensus rating and higher probable upside, analysts clearly believe Mirion Technologies is more favorable than Camtek.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Camtek
0 Sell rating(s)
7 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.50
Mirion Technologies
1 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.80

Summary

Camtek beats Mirion Technologies on 9 of the 16 factors compared between the two stocks.

How does Mirion Technologies compare to Bio-Rad Laboratories?

Mirion Technologies (NYSE:MIR) and Bio-Rad Laboratories (NYSE:BIO.B) are both mid-cap measuring and control equipment companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, media sentiment, valuation, risk, earnings, analyst recommendations and profitability.

Mirion Technologies currently has a consensus target price of $27.13, suggesting a potential upside of 36.09%. Given Mirion Technologies' stronger consensus rating and higher possible upside, equities research analysts clearly believe Mirion Technologies is more favorable than Bio-Rad Laboratories.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Mirion Technologies
1 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.80
Bio-Rad Laboratories
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Mirion Technologies has a beta of 1.07, indicating that its stock price is 7% more volatile than the S&P 500. Comparatively, Bio-Rad Laboratories has a beta of 0.96, indicating that its stock price is 4% less volatile than the S&P 500.

Bio-Rad Laboratories has a net margin of 6.52% compared to Mirion Technologies' net margin of 2.56%. Mirion Technologies' return on equity of 6.44% beat Bio-Rad Laboratories' return on equity.

Company Net Margins Return on Equity Return on Assets
Mirion Technologies2.56% 6.44% 3.48%
Bio-Rad Laboratories 6.52%3.56%2.49%

In the previous week, Mirion Technologies had 12 more articles in the media than Bio-Rad Laboratories. MarketBeat recorded 17 mentions for Mirion Technologies and 5 mentions for Bio-Rad Laboratories. Bio-Rad Laboratories' average media sentiment score of 0.96 beat Mirion Technologies' score of 0.79 indicating that Bio-Rad Laboratories is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Mirion Technologies
9 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Bio-Rad Laboratories
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Bio-Rad Laboratories has higher revenue and earnings than Mirion Technologies. Bio-Rad Laboratories is trading at a lower price-to-earnings ratio than Mirion Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Mirion Technologies$925.40M5.40$28.80M$0.10199.32
Bio-Rad Laboratories$2.58B2.73$759.90M$6.0743.04

78.5% of Mirion Technologies shares are held by institutional investors. Comparatively, 0.0% of Bio-Rad Laboratories shares are held by institutional investors. 6.3% of Mirion Technologies shares are held by company insiders. Comparatively, 28.4% of Bio-Rad Laboratories shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Mirion Technologies beats Bio-Rad Laboratories on 11 of the 17 factors compared between the two stocks.

How does Mirion Technologies compare to Sensata Technologies?

Mirion Technologies (NYSE:MIR) and Sensata Technologies (NYSE:ST) are both mid-cap measuring and control equipment companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and media sentiment.

Mirion Technologies has a beta of 1.07, suggesting that its stock price is 7% more volatile than the S&P 500. Comparatively, Sensata Technologies has a beta of 1.21, suggesting that its stock price is 21% more volatile than the S&P 500.

Sensata Technologies has higher revenue and earnings than Mirion Technologies. Sensata Technologies is trading at a lower price-to-earnings ratio than Mirion Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Mirion Technologies$925.40M5.40$28.80M$0.10199.32
Sensata Technologies$3.73B1.76$31.30M$0.31145.68

In the previous week, Mirion Technologies had 8 more articles in the media than Sensata Technologies. MarketBeat recorded 17 mentions for Mirion Technologies and 9 mentions for Sensata Technologies. Mirion Technologies' average media sentiment score of 0.79 beat Sensata Technologies' score of 0.69 indicating that Mirion Technologies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Mirion Technologies
9 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Sensata Technologies
2 Very Positive mention(s)
4 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Mirion Technologies has a net margin of 2.56% compared to Sensata Technologies' net margin of 1.28%. Sensata Technologies' return on equity of 18.23% beat Mirion Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Mirion Technologies2.56% 6.44% 3.48%
Sensata Technologies 1.28%18.23%7.34%

78.5% of Mirion Technologies shares are held by institutional investors. Comparatively, 99.4% of Sensata Technologies shares are held by institutional investors. 6.3% of Mirion Technologies shares are held by insiders. Comparatively, 0.9% of Sensata Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Mirion Technologies currently has a consensus target price of $27.13, suggesting a potential upside of 36.09%. Sensata Technologies has a consensus target price of $43.10, suggesting a potential downside of 4.56%. Given Mirion Technologies' stronger consensus rating and higher possible upside, equities analysts plainly believe Mirion Technologies is more favorable than Sensata Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Mirion Technologies
1 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.80
Sensata Technologies
1 Sell rating(s)
6 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.27

Summary

Mirion Technologies beats Sensata Technologies on 10 of the 17 factors compared between the two stocks.

Get Mirion Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for MIR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MIR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MIR vs. The Competition

MetricMirion TechnologiesTechnology Services IndustryBusiness SectorNYSE Exchange
Market Cap$4.99B$3.81B$6.43B$23.09B
Dividend YieldN/A2.12%3.08%4.03%
P/E Ratio199.2043.1427.4628.67
Price / Sales5.4051.15447.4414.71
Price / Cash18.6039.8823.4125.32
Price / Book2.645.655.894.62
Net Income$28.80M$29.84M$200.33M$1.07B
7 Day Performance1.02%2.77%1.50%0.89%
1 Month Performance4.75%9.64%6.55%7.12%
1 Year Performance23.53%40.85%56.65%31.61%

Mirion Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MIR
Mirion Technologies
4.3985 of 5 stars
$19.93
-2.2%
$27.13
+36.1%
+26.3%$4.99B$925.40M199.203,281
NVMI
Nova
2.9945 of 5 stars
$510.15
-3.8%
$442.25
-13.3%
+175.7%$16.19B$880.58M63.621,612
RVTY
Revvity
2.2686 of 5 stars
$84.67
-2.4%
$110.17
+30.1%
+9.9%$9.55B$2.86B41.0911,000
CAMT
Camtek
2.7705 of 5 stars
$187.13
-2.0%
$166.75
-10.9%
+201.0%$8.59B$496.07M199.47400
BIO.B
Bio-Rad Laboratories
N/A$299.45
+8.1%
N/A+11.5%$8.08B$2.58B10.738,200

Related Companies and Tools


This page (NYSE:MIR) was last updated on 5/7/2026 by MarketBeat.com Staff.
From Our Partners